摘要 |
<p>The present invention provides rotavirus reassortant immunogenic compositions based on a porcine rotavirus. In particular, porcine rotavirus Gottfried strain -based single VP7 or VP4 gene substitutions which can provide (i) an attenuation phenotype of a porcine rotavirus in humans and (ii) antigenic coverage for G serotypes 1, 2, 3, 4, 5, 6, 8, 9 and 10 and P serotype 1A[8], 1B[4] and 2A[6]. The compositions have been demonstrated to induce consistent levels of neutralizing antibodies against rotavirus specificities which are of global epidemiologic importance. Porcine rotavirus-based reassortant rotavirus compositions induce neutralizing antibodies against P1A[8] and P2A[6] VP4 serotypes which may provide an advantage over rhesus- or bovine-based reassortant vaccines since the VP4s of the latter vaccines do not evoke antibodies capable of neutralizing the P1A[8], or P2A[6] VP4.</p> |